May 26, 2026. According to Reuters, major tobacco companies may emerge as the primary beneficiaries after the U.S. Food and Drug Administration (FDA) recently relaxed its regulatory stance on vapes and nicotine pouches.
Key Highlights
- FDA relaxes vape regulations.
- Hundreds of products poised to benefit;
- Tobacco firms have long lobbied for policy adjustments;
- Public health risks spark controversy.
FDA Shifts to Enforcement Discretion for Pending Vape Applications
The report states that earlier this month. The FDA announced it would exercise enforcement discretion regarding certain unauthorized vape products for which marketing applications have already been submitted. Provided the relevant applications meet specific criteria. The regulatory agency may temporarily refrain from taking enforcement action, allowing these products to remain on the market during the review process.
Market Impact: Hundreds of Products Poised to Enter the U.S. Market
Citing current and former Trump administration officials. Reuters reported that the new policy could facilitate the entry of hundreds of vape and nicotine pouch products into the U.S. market. One official indicated that approximately 100 to 200 products could immediately benefit, while roughly 1,000 product applications have advanced to the FDA’s scientific review stage.
Political Influence: Massive Industry Donations Precede Regulatory Shifts
Major tobacco companies and industry groups have collectively donated over $22 million to Trump-affiliated political organizations and Super PACs. Reynolds American alone contributed approximately $18 million, followed by Altria ($2M) and the Vapor Technology Association ($1.3M). Industry executives argue that previous restrictive policies fueled a massive illicit market dominated by Chinese imports.
Combating the $8 Billion Illicit Market Dominance
Market research firm Euromonitor estimates that at least 70% of vape sales in the U.S. currently consist of illicit products, a market projected to reach approximately $8 billion in 2024. The new guidance aims to strengthen enforcement against unauthorized nicotine products while facilitating a transition toward a regulated, legal market system.
Public Health Concerns: Advocacy Groups Warn of Increased Youth Access
Anti-tobacco groups, such as the Campaign for Tobacco-Free Kids, argue that the new policy could facilitate the legal sale of a wider range of flavored vapes and increase the risk of exposure among adolescents. While youth vape usage has declined from its 2019 peak, experts warn that bypassing formal rulemaking processes could jeopardize public trust and health outcomes.
Trump Administration Frames Vapes as Harm Reduction and Voter Appeal
White House officials noted that Trump supports expanding access to vapes and nicotine pouches as alternatives to assist adults in quitting smoking. Additionally, reports suggest that the administration views vape products as crucial for maintaining the support of young male voters, a key demographic in recent political campaigns.
Financial Forecasts: Zyn and Vuse Expected to Lead Industry Sales Surge
Industry analysts believe the new policies will drive increased sales. Barclays analyst Pallav Mittal projects that Philip Morris International could sell an additional 12 million units of its Zyn nicotine pouches this year. Analysts also suggested that Reynolds might introduce flavored versions of its Vuse brand vapes to capture additional market share.
Regulatory Criticism: Warning of Political Influence and Health Risks
Mitch Zeller, the former head of tobacco regulation at the FDA, warned that adult smokers could end up using products that have not been fully vetted. He stated that political influence on the FDA is detrimental to public health and erodes public trust in government safety standards.
Follow us to get more updates: @zumo.official
